A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential

Journal of Medicinal Chemistry

Volumn 46, Issue 12, 2003, Pages 2334-2344

  Lewis, Ian ^a   Bauer, Wilfried ^a   Albert, Rainer ^a   Chandramouli, Nagarajan ^a   Pless, Janos ^a   Weckbecker, Gisbert ^a   Bruns, Christian ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; CYCLO(PROLYLPHENYLALANYL DEXTRO TRYPTOPHYLLYSYLTHREONYLPHENYLALANYL); HEXAPEPTIDE; OCTREOTIDE; PASIREOTIDE; SEGLITIDE; SOMATOMEDIN C; SOMATOSTATIN 14; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG; VAPREOTIDE;

ARTICLE; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; CHO CELLS; COS CELLS; CRICETINAE; DRUG DESIGN; HUMANS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR MIMICRY; OLIGOPEPTIDES; PEPTIDES, CYCLIC; RADIOLIGAND ASSAY; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0038440483     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm021093t     Document Type: Article

References (44)

1. Brazeau, P.; Vale, W.; Burgus, R.; Ling, N.; Butcher, M.; Rivier, J.; Guillemin, R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973, 179, 77-79.
2. Epelbaum, J. Somatostatin in the central nervous system: physiology and pathological modifications. Prog. Neurobiol. 1986, 27, 63-100.
3. Hoyer, D.; Luebbert, H.; Bruns, C. Molecular pharmacology of somatostatin receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1994, 350 (5), 441-453.
4. Bruns, C.; Weckbecker, G.; Raulf, F.; Kaupmann, K.; Schoeffter, P.; Hoyer, D.; Lubbert, H. Molecular pharmacology of somatostatin-receptor subtypes. Ann. N. Y. Acad. Sci. 1994, 733 13846.
5. Patel, Y. C. Somatostatin and its receptor family. Front. Neuroendocrinol. 1999, 20, 157-198.
6. Hannon, J. P.; Bruns, C.; Weckbecker, G.; Hoyer, D. Somatostatin receptor gene family-subtype selectivity for ligand binding. In Somatostatin; Patel, Y. C., Ed.; in press.
7. Reisine, T.; Bell, G. I. Molecular properties of somatostatin receptors. Neuroscience 1995, 67, 777-790.
8. Reisine, T.; Bell, G. I. Molecular biology of somatostatin receptors. Endocr. Rev. 1995, 16, 427-442.
9. Bruns, C.; Weckbecker, G.; Raulf, F.; Lübbert, H.; Hoyer, D. Characterization of somatostatin receptor subtypes. In Somatostatin and Its Receptors, Reichlin, S., Ed.; Ciba Foundation Symposium 190; Wiley: Chichester, 1995, pp 89-110.
10. Froidevaux, S.; Eberle, A N. Somatostatin analogs and radiopeptides in cancer therapy. Biopolymers 2002, 66 (3), 161-183.
11. Bauer, W.; Briner, U.; Doepfner, W.; Haller, R.; Huguenin, R.; Marbach, P.; Petcher, T.; Pless, J. SMS 201-995: A very potent and selective analogue of Somatostatin with prolonged action. Life Sci. 1980, 31, 1134-1140.
12. Murphy, W. A.; Lance, V A.; Moreau, S.; Moreau, J.; Coy, D. H. Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin. Life Sci. 1987, 40, 2515-2522.
13. Coy, D. H.; Taylor, J. E. Receptor-specific somatostatin analogues: Correlations with biological activity. Metabolism 1996, 34 (1), 21-23.
14. Cai, R. Z.; Szoke, B.; Lu, R.; Fu, D.; Redding, T. W.; Schally, A. V. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin. Proc. Natl. Acad. Sci. U.S.A. 1986, 83 (6), 1896-1900.
15. Karashima, T.; Cai, R. Z.; Schally, A. V. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release. Life Sci. 1987, 41, 1011-1019.
16. Patel, Y. C.; Wheatley, T. In vivo and in vitro plasma disappearance and metabolism of somatostatin-28 and somatostatin14 in the rat. Endocrinology 1983, 112 (1), 220-225.
17. Lamberts, S. W. J.; Van Der Lely, A. J.; De Herder, W. W.; Hofland, L. J. Octreotide. N. Engl. J. Med. 1996, 334, 246-254.
18. Veber, D. F.; Freidinger, R. M.; Perlow, D. S., Jr.; Palaveda, W. J.; Holly, F. W.; Strachan, R. G.; Nutt, R. F.; Arison, B. J.; Homnick, C.; Randall, W. C.; Glitzer, M. S.; Saperstein, R.; Hirschmann, R. A potent cyclic hexapeptide analogue of somatostatin. Nature 1981, 292, 55-58.
19. Veber, D. F. Design of a highly active cyclic hexapeptide analogue of somatostatin. In Peptides: Synthesis, Structure and Function. Proceedings of the Seventh American Peptide Symposium; Rich, D. H., Gross, V. J., Eds.; Pierce Chemical Co.: Rockford, IL, 1981; pp 685-694.
20. Veber, D. F.; Saperstein, R.; Nutt, R. F.; Freidinger, R. M.; Brady, S. F.; Curley, P.; Perlow, D. S.; Paleveda, W. J.; Colton, C. D.; Zacchei, A. G. A super active cyclic hexapeptide analog of somatostatin. Life Sci. 1984, 34 (14), 1371-1378.
21. Freidinger, R. M.; Perlow, D. S.; Randall, W. C.; Saperstein, R.; Arison, B. H.; Veber, D. F. Conformational modifications of cyclic hexapeptide somatostatin analogs. Int. J. Pept. Protein Res. 1984, 23 (2), 142-150.
22. Nutt, R. F.; Colton, C. D.; Saperstein, R.; Veber, D. F. Side Chain Conformations of Somatostatin Analogs When Bound to Receptors. In Somatostatin; Reichlin, S., Ed.; Plenum Publishing Corp.: New York, 1987; pp 83-87.
23. Veber, D. F. Design and discovery in the development of peptide analogs. In Peptides: Chemistry and Biology. Proceedings of the Twelfth American Peptide Symposium; Smith, J. A., Rivier, J. E., Eds.; ESCOM, Leiden, 1992; pp 3-14.
24. Lamberts, S. W. J.; van der Lely, A. J.; Hofland, L. J. New somatostatin analogs: Will they fulfil old promises? Eur. J. Endocrinol. 2002, 146 (5), 701-705.
25. Rohrer, S. P.; Birzin, E. T.; Mosley, R. T.; Berk, S. C.; Hutchins, S. M.; Shen, D. M.; Xiong, Y.; Hayes, E. C.; Parmar, R. M.; Foor, F.; Mitra, S. W.; Degrado, S. J.; Shu, M.; Klopp, J. M.; Cai, S. J.; Blake, A.; Chan, W. W.; Pasternak, A.; Yang, L.; Patchett, A. A.; Smith, R. G.; Chapman, K. T.; Schaeffer, J. M. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science (Washington, D.C.) 1998, 282, 737-740.
26. Yang, L.; Berk, S. C.; Rohrer, S. P.; Mosley, R. T.; Guo, L.; Underwood, D. J.; Arison, B. H.; Birzin, E. T.; Hayes, E. C.; Mitra, S. W.; Parmar, R. M.; Cheng, K.; Wu, T. J.; Butler, B. S.; Foor, F.; Pasternak, A.; Pan, Y.; Silva, M.; Freidinger, R. M.; Smith, R. G.; Chapman, K.; Schaeffer, J. M.; Patchett, A. A. Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 10836-10841.
27. Rivier, J.; Brown, M.; Rivier, C.; Ling, N.; Vale, W. Hypothalamic hypophysiotropic hormones: review on the design of synthetic analogs. In Peptides 1976; Loffet, A., Eds.; Editions de l'Universites: Bruxelles, Belgium, 1976; Vol. V; pp 427-521.
28. Bernatowicz, M. S.; Daniels, S. B.; Koster, H. A comparison of acid-labile linkage agents for the synthesis of peptide C-terminal amides. Tetrahedron Lett. 1989, 30 (35), 4645-4648.
29. Mattern R.-H.; Moore, S. B.; Tran, T.-A.; Rueter, J. K.; Goodman, M. Synthesis, Biological Activities and Conformational Studies of Somatostatin Analogs. Tetrahedron 2000, 56, 9819-9831.
30. Falb, E.; Salitra, Y.; Yechezkel, T.; Bracha, M.; Litman, P.; Olender, R.; Rosenfeld, R.; Senderowitz, H.; Jiang, S.; Goodman, M. A bicyclic and hsst2 selective somatostatin analogue: design, synthesis, conformational analysis and binding. Bioorg. Med. Chem. 2001, 9 (12), 3255-3264.
31. Thompson, L. A.; Ellman, J. A. Straightforward and general method for coupling alcohols to solid supports. Tetrahedron Lett. 1994, 35 (50), 9333-9336.
32. Lewis, I.; Bauer, W.; Albert, R.; Chandramouli, N.; Pless, J.; Engel, G.; Weckbecker, G.; Bruns, C. Rational approach to stable, universal somatostatin analogues with superior therapeutic potential. In Peptides: The Wave of the Future. Proceedings of the Second International and the Seventeenth American Peptide Symposium; Houghten, R., Lebl, M., Eds.; American Peptide Society: San Diego, CA, 2001; pp 718-720.
33. Bruns, C.; Raulf, F.; Hoyer, D.; Schloos, J.; Luebbert, H.; Weckbecker, G.; Binding properties of somatostatin receptor subtypes. Metab., Clin Exp. 1996, 44 (8, Suppl. 1), 17-20.
34. Bruns, C.; Lewis, I.; Briner, U.; Meno-Tetang, G.; Weckbecker, G. SOM230: a novel somatostatin peptidomimetic with a broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur. J. Endocrinol. 2002, 146, 707-716.
35. Weckbecker, G.; Briner, U.; Lewis, I.; Bruns, C. SOM230: a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone/insulin-like growth factor-I axis in rats, primates, and dogs. Endocrinology 2002, 143 (10), 4123-4130.
36. Souers, A. J.; Virgilio, A. A.; Rosenquist, S. A.; Fenuik, W.; Ellman, J. A. Identification of a Potent Heterocyclic Ligand to Somatostatin Receptor Subtype 5 by the Synthesis and Screening of β-Turn Mimetic Libraries. J. Am. Chem. Soc. 1999, 121 (9), 1817-1825.
37. Gademann, K.; Kimmerlin, T.; Hoyer, D.; Seebach, D. Peptide folding induces high and selective affinity of a linear and small β-peptide to the human somatostatin receptor 4. J. Med. Chem. 2001, 44 (15), 2460-2468.
38. Rivier, J. E.; Hoeger, C.; Erchegyi, J.; Gulyas, J.; DeBoard, R.; Craig, A. G.; Koerber, S. C.; Wenger, S.; Waser, B.; Schaer, J.C.; Reubi, J. C. Potent Somatostatin Undecapeptide Agonists Selective for Somatostatin Receptor 1 (sst1). J. Med. Chem. 2001, 44 (13), 2238-2246.
39. Rajeswaran, W. G.; Hocart, S. J.; Murphy, W. A.; Taylor, J. E.; Coy, D. H. Highly Potent and Subtype Selective Ligands Derived by N-Methyl Scan of a Somatostatin Antagonist. J. Med. Chem. 2001, 44 (8), 1305-1311.
40. Rajeswaran, W. G.; Hocart, S. J.; Murphy, W. A.; Taylor, J. E.; Coy, D. H. N-Methyl Scan of Somatostatin Octapeptide Agonists Produces Interesting Effects on Receptor Subtype Specificity. J. Med. Chem. 2001, 44 (9), 1416-1421.
41. Poitout, L.; Roubert, P.; Contour-Galcera, M.-O.; Moinet, C.; Lannoy, J.; Pommier, J.; Plas, P.; Bigg, D.; Thurieau, C. Identification of Potent Non-Peptide Somatostatin Antagonists with sst3 Selectivity. J. Med. Chem. 2001, 44 (18), 2990-3000.
42. Contour-Galcera, M.-O.; Poitout, L.; Moinet, C.; Morgan, B.; Gordon, T.; Thurieau, C. Synthesis of substituted imidazopyrazines as ligands for the human somatostatin receptor subtype 5. Bioorg. Med. Chem. Lett. 2001, 11 (5), 741-745.
43. Gazal, S.; Gelerman, G.; Ziv, O.; Karpov, O.; Litman, P.; Bracha, M.; Afargan, M.; Gilon, C. Human Somatostatin Receptor Specificity of Backbone-Cyclic Analogues Containing Novel Sulfur Building Units. J. Med. Chem. 2002, 45 (8), 1665-1671.
44. Reubi, J. C.; Eisenwiener, K.-P.; Rink, H.; Waser, B.; Macke, H. R. A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors. Eur. J. Pharmacol. 2002, 456 (13), 45-49.